Quantitative proteomics and transcriptomics reveals metabolic differences in attracting and non-attracting human-in-mouse glioma stem cell xenografts and stromal cells
Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) show promise as cell-based delivery vehicles for anti-glioma therapeutics, due to innate tropism for gliomas. However, in clinically relevant human-in-mouse glioma stem cell xenograft models, BM-hMSCs tropism is variable. We compared the pr...
Main Authors: | Norelle C. Wildburger, Cheryl F. Lichti, Richard D. LeDuc, Mary Schmidt, Roger A. Kroes, Joseph R. Moskal, Carol L. Nilsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-09-01
|
Series: | EuPA Open Proteomics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221296851530009X |
Similar Items
-
Persistency of Mesenchymal Stromal/Stem Cells in Lungs
by: Erica Ferrini, et al.
Published: (2021-07-01) -
Impact of Tranexamic Acid on Chondrocytes and Osteogenically Differentiated Human Mesenchymal Stromal Cells (hMSCs) In Vitro
by: Mike Wagenbrenner, et al.
Published: (2020-11-01) -
Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel System
by: Josephine Lembong, et al.
Published: (2020-07-01) -
Mesenchymal Stromal Cells as a Cellular Target in Myeloid Malignancy: Chances and Challenges in the Genome Editing of Stromal Alterations
by: Bella Banjanin, et al.
Published: (2021-01-01) -
Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders
by: Carmela Dell’Aversana, et al.
Published: (2019-03-01)